ELTP - Elite Pharmaceuticals GAAP EPS of $0.00 revenue of $8.59M
- Elite Pharmaceuticals press release ( OTCQB:ELTP ): FQ2 GAAP EPS of $0.00.
- Revenue of $8.59M (+0.4% Y/Y).
- As of September 30, 2022, and March 31, 2022, the Company had $0.41M and $0.41M, of restricted cash, respectively, related to debt service reserve in regard to the New Jersey Economic Development Authority bonds.
- 10Q
For further details see:
Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $8.59M